AN2 Therapeutics, Inc. (ANTX) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

AN2 Therapeutics, Inc. (ANTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $118.7M, listed on NASDAQ, employing roughly 22 people, carrying a beta of -0.96 to the broader market. AN2 Therapeutics, Inc. Led by Eric E. Easom, public since 2022-03-25.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for ANTX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →